Rituximab reduced atherosclerosis progression in RA patients Healio Rituximab therapy reduced the progression of accelerated atherosclerosis in patients with rheumatoid arthritis, according to study results. Researchers in Italy studied 38 patients with rheumatoid arthritis (RA; mean age, 66.7 years; 33 women) who ... |
